The Janus face of myofibroblasts in the remodeling heart

Journal of Molecular and Cellular Cardiology

Volumn 91, Issue , 2016, Pages 35-41

  Hermans, Kevin C M ^a   Daskalopoulos, Evangelos P ^b,c   Blankesteijn, W Matthijs ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Cardiovascular Research Institute   (Greece)

Author keywords

Cardiac fibrosis; Epithelial to mesenchymal transition; Fibrocyte; Mesenchymal stem cell; Myofibroblast; Signaling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; CONNEXIN 43; HERMES ANTIGEN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR NANOG; ACTA2 PROTEIN, HUMAN; ACTIN; CATHEPSIN L; CTSL1 PROTEIN, HUMAN; SERUM AMYLOID P;

ANTIGEN EXPRESSION; ARRHYTHMOGENESIS; CELL ACTIVATION; CELL DENSITY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CARDIAC MUSCLE; CELL DIFFERENTIATION; DRUG EFFECTS; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART ARRHYTHMIA; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ACTINS; ANIMALS; ARRHYTHMIAS, CARDIAC; CATHEPSIN L; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOFIBROBLASTS; SERUM AMYLOID P-COMPONENT; SIGNAL TRANSDUCTION;

EID: 84952911245     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.017     Document Type: Review

References (69)

1. Papageorgiou A., Rienks M. Novel regulators of cardiac inflammation: matricellular proteins expand their repertoire. J. Mol. Cell. Cardiol. 2015, (in press).
2. Frangogiannis N.G. Regulation of the inflammatory response in cardiac repair. Circ. Res. 2012, 110:159-173.
3. van Nieuwenhoven F.A., Turner N.A. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vasc. Pharmacol. 2013, 58:182-188.
4. Kong P., Christia P., Frangogiannis N.G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 2014, 71:549-574.
5. Lindsey M.L., Iyer R.P., Jung M., DeLeon-Pennell K.Y., Ma Y. Matrix metalloproteinases as input and output signals for post-Myocardial infarction remodeling. J Mol Cell Cardiol. 2015, (in press).
6. Camelliti P., Borg T.K., Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 2005, 65:40-51.
7. van den Borne S.W., Diez J., Blankesteijn W.M., Verjans J., Hofstra L., Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 2010, 7:30-37.
8. Hinz B., Phan S.H., Thannickal V.J., Prunotto M., Desmouliere A., Varga J., et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 2012, 180:1340-1355.
9. Turner N.A., Porter K.E. Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair 2013, 6:5.
10. Cleutjens J.P.M., Blankesteijn W.M., Daemen M.J.A.P., Smits J.F.M. The infarcted myocardium: simply dead tissue or a lively target for therapeutic interventions. Cardiovasc. Res. 1999, 44:232-241.
11. Driskell R.R., Lichtenberger B.M., Hoste E., Kretzschmar K., Simons B.D., Charalambous M., et al. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature 2013, 504:277-281.
12. Gabbiani G., Ryan G.B. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971, 27:549-550.
13. Zeisberg E.M., Kalluri R. Origins of cardiac fibroblasts. Circ. Res. 2010, 107:1304-1312.
14. Haudek S.B., Xia Y., Huebener P., Lee J.M., Carlson S., Crawford J.R., et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18284-18289.
15. Yano T., Miura T., Ikeda Y., Matsuda E., Saito K., Miki T., et al. Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovasc. Pathol. 2005, 14:241-246.
16. Daskalopoulos E.P., Hermans K.C., Blankesteijn W.M. Cardiac (myo)fibroblast: Novel strategies for its targeting following myocardial infarction. Curr. Pharm. Des. 2014, 20:1987-2002.
17. Deb A., Ubil E. Cardiac fibroblast in development and wound healing. J. Mol. Cell. Cardiol. 2014, 70:47-55.
18. Dobaczewski M., Chen W., Frangogiannis N.G. Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 2011, 51:600-606.
19. Serini G., Bochaton-Piallat M.L., Ropraz P., Geinoz A., Borsi L., Zardi L., et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J. Cell Biol. 1998, 142:873-881.
20. Leask A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ. Res. 2015, 116:1269-1276.
21. Kovacic J.C., Mercader N., Torres M., Boehm M., Fuster V. Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation 2012, 125:1795-1808.
22. Acharya A., Baek S.T., Huang G., Eskiocak B., Goetsch S., Sung C.Y., et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012, 139:2139-2149.
23. Gittenberger-de Groot A.C., Vrancken Peeters M.P., Mentink M.M., Gourdie R.G., Poelmann R.E. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ. Res. 1998, 82:1043-1052.
24. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 1995, 77:1-6.
25. Turner N.A. Inflammatory and Fibrotic Responses of Cardiac Fibroblasts to Myocardial Damage Associated Molecular Patterns (DAMPs). J. Mol. Cell. Cardiol. 2016.
26. Willems I.E.M.G., Havenith M.G., De Mey J.G.R., Daemen M.J.A.P. The α-smooth muscle actin-positive cells in healing human myocardial scars. Am. J. Pathol. 1994, 145:868-875.
27. van den Borne S.W., van de Schans V.A., Strzelecka A.E., Vervoort-Peters H.T., Lijnen P.M., Cleutjens J.P., et al. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc. Res. 2009, 84:273-282.
28. Sorescu D., Griendling K.K. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest. Heart Fail. 2002, 8:132-140.
29. Hermans K.C., Blankesteijn W.M. Wnt Signaling in Cardiac Disease. Compr. Physiol. 2015, 5:1183-11209.
30. Da Costa Martins P.A., De Windt L.J. Targeting microRNA targets. Circ. Res. 2012, 111:506-508.
31. Daskalopoulos E.P., Vilaeti A.D., Barka E., Mantzouratou P., Kouroupis D., Kontonika M., et al. Attenuation of post-infarction remodeling in rats by sustained myocardial growth hormone administration. Growth Factors 2015, 1-9.
32. Laeremans H., Daskalopoulos E.P., Janssen B., Blankesteijn W.M. Blocking of Wnt/Frizzled Signaling Stops the Dilatation of the Left Ventricle After Myocardial Infarction. Circulation 2011, 124.
33. Drazner M.H. The progression of hypertensive heart disease. Circulation 2011, 123:327-334.
34. Berk B.C., Fujiwara K., Lehoux S. ECM remodeling in hypertensive heart disease. J. Clin. Investig. 2007, 117:568-575.
35. Weber K.T., Sun Y., Bhattacharya S.K., Ahokas R.A., Gerling I.C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 2013, 10:15-26.
36. Vesely I. Heart valve tissue engineering. Circ. Res. 2005, 97:743-755.
37. Jana S., Tranquillo R.T., Lerman A. Cells for tissue engineering of cardiac valves. J. Tissue Eng. Regen. Med. 2015.
38. Stuart S.D., DJ N.M., Lindsey M.L., Ripplinger C.M. The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J. Mol. Cell. Cardiol. 2015, (in press).
39. Nguyen T.P., Qu Z., Weiss J.N. Cardiac fibrosis and arrhythmogenesis: the road to repair is paved with perils. J. Mol. Cell. Cardiol. 2014, 70:83-91.
40. Askar S.F., Ramkisoensing A.A., Schalij M.J., Bingen B.O., Swildens J., van der Laarse A., et al. Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization. Cardiovasc. Res. 2011, 90:295-304.
41. Rosker C., Salvarani N., Schmutz S., Grand T., Rohr S. Abolishing myofibroblast arrhythmogeneicity by pharmacological ablation of alpha-smooth muscle actin containing stress fibers. Circ. Res. 2011, 109:1120-1131.
42. Shin S.Y., Jo W.M., Min T.J., Kim B.K., Song D.H., Hyeon S.H., et al. Gap junction remodelling by chronic pressure overload is related to the increased susceptibility to atrial fibrillation in rat heart. Europace 2015, 17:655-663.
43. Zhang Y., Kanter E.M., Yamada K.A. Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication. Cardiovasc. Pathol. 2010, 19:e233-e240.
44. Askar S.F., Bingen B.O., Swildens J., Ypey D.L., van der Laarse A., Atsma D.E., et al. Connexin43 silencing in myofibroblasts prevents arrhythmias in myocardial cultures: role of maximal diastolic potential. Cardiovasc. Res. 2012, 93:434-444.
45. Tondato F., Robinson K., Cui J., Goodchild T., Chronos N., Peters N.S. Effects on arrhythmogenesis and arrhythmic threshold of injection of autologous fibroblasts into myocardial infarcts in adult pigs. J. Cardiovasc. Transl. Res. 2012, 5:337-344.
46. Tondato F., Zeng H., Goodchild T., Ng F.S., Chronos N., Peters N.S. Autologous dermal fibroblast injections slow atrioventricular conduction and ventricular rate in atrial fibrillation in swine. Circ. Arrhythm. Electrophysiol. 2015, 8:439-446.
47. McDowell K.S., Arevalo H.J., Maleckar M.M., Trayanova N.A. Susceptibility to arrhythmia in the infarcted heart depends on myofibroblast density. Biophys. J. 2011, 101:1307-1315.
48. Carlson S., Trial J., Soeller C., Entman M.L. Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovasc. Res. 2011, 91:99-107.
49. van Wijk B., Gunst Q.D., Moorman A.F., van den Hoff M.J. Cardiac regeneration from activated epicardium. PLoS ONE 2012, 7:e44692.
50. Ruiz-Villalba A., Simon A.M., Pogontke C., Castillo M.I., Abizanda G., Pelacho B., et al. Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. J. Am. Coll. Cardiol. 2015, 65:2057-2066.
51. Braitsch C.M., Kanisicak O., van Berlo J.H., Molkentin J.D., Yutzey K.E. Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J. Mol. Cell. Cardiol. 2013, 65:108-119.
52. Gonzalez-Rosa J.M., Peralta M., Mercader N. Pan-epicardial lineage tracing reveals that epicardium derived cells give rise to myofibroblasts and perivascular cells during zebrafish heart regeneration. Dev. Biol. 2012, 370:173-186.
53. Chen W., Frangogiannis N.G. Fibroblasts in post-infarction inflammation and cardiac repair. BBA 1833, 2013:945-953.
54. Trial J., Cieslik K.A., Entman M. Mesenchymal Stem Cell-derived Inflammatory Fibroblasts Mediate Interstitial Fibrosis in the Aging Heart. J. Mol. Cell. Cardiol. 2015, (in press).
55. Cieslik K.A., Trial J., Entman M.L. Defective myofibroblast formation from mesenchymal stem cells in the aging murine heart rescue by activation of the AMPK pathway. Am. J. Pathol. 2011, 179:1792-1806.
56. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., JR M.M., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13:952-961.
57. Sopel M.J., Rosin N.L., Lee T.D., Legare J.F. Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells. Lab. Investig. 2011, 91:565-578.
58. Moore-Morris T., Guimaraes-Camboa N., Banerjee I., Zambon A.C., Kisseleva T., Velayoudon A., et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Investig. 2014, 124:2921-2934.
59. Mackinnon A., Forbes S. Bone marrow contributions to fibrosis. BBA 1832, 2013:955-961.
60. Crawford J.R., Haudek S.B., Cieslik K.A., Trial J., Entman M.L. Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts. J. Cardiovasc. Transl. Res. 2012, 5:749-759.
61. Falkenham A., Sopel M., Rosin N., Lee T.D., Issekutz T., Legare J.F. Early fibroblast progenitor cell migration to the AngII-exposed myocardium is not CXCL12 or CCL2 dependent as previously thought. Am. J. Pathol. 2013, 183:459-469.
62. Sun M., Chen M., Liu Y., Fukuoka M., Zhou K., Li G., et al. Cathepsin-L contributes to cardiac repair and remodelling post-infarction. Cardiovasc. Res. 2011, 89:374-383.
63. Bronnum H., Andersen D.C., Schneider M., Nossent A.Y., Nielsen S.B., Sheikh S.P. Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells. Exp. Cell Res. 2013, 319:424-435.
64. Cosentino S., Castiglioni L., Colazzo F., Nobili E., Tremoli E., Rosa P., et al. Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction. J. Cell. Mol. Med. 2014, 18:1785-1796.
65. Liang H., Hou H., Yi W., Yang G., Gu C., Lau W.B., et al. Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury. Eur. Heart J. 2013, 34:1681-1690.
66. Chen P., Wu R., Zhu W., Jiang Z., Xu Y., Chen H., et al. Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin. PLoS ONE 2014, 9:e103587.
67. Ngo M.A., Muller A., Li Y., Neumann S., Tian G., Dixon I.M., et al. Human mesenchymal stem cells express a myofibroblastic phenotype in vitro: comparison to human cardiac myofibroblasts. Mol. Cell. Biochem. 2014, 392:187-204.
68. Ryzhov S., Sung B.H., Zhang Q., Weaver A., Gumina R.J., Biaggioni I., et al. Role of adenosine A2B receptor signaling in contribution of cardiac mesenchymal stem-like cells to myocardial scar formation. Purinergic Signal 2014, 10:477-486.
69. Cieslik K.A., Trial J., Carlson S., Taffet G.E., Entman M.L. Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels. FASEB J. 2013, 27:1761-1771.